International Clinical Trial: Pucotenlimab Combined with Lenvatinib and eribulin in Patients with Advanced Sarcoma Failed in First-Line Therapy, a Single-Arm, Open-Label, Multicenter, Phase II Clinical Study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115523) titled 'Pucotenlimab Combined with Lenvatinib and eribulin in Patients with Advanced Sarcoma Failed in First-Line Therapy, a Single-Arm, Open-Label, Multicenter, Phase II Clinical Study' on Dec. 26, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanghai Sixth People's Hospital

Condition: Sarcoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-01-01

Target Sample Size: Experimental group:33;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=301505

Published by HT Digital Content Services with permis...